NewslettersIntestinal Cell NewsUncategorizedCetuximab Promotes RSL3-Induced Ferroptosis by Suppressing the Nrf2/HO-1 Signalling Pathway in KRAS Mutant Colorectal CancerBy Justin.choi - November 15, 2021011Researchers investigated whether cetuximab-mediated regulation of p38/Nrf2/HO-1 promoted RSL3-induced ferroptosis and played a pivotal role in overcoming drug resistance in KRAS mutant colorectal cancer.[Cell Death & Disease] 6445212 AAAAAAAA items 1 apa 0 default asc 1 168928 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article